Specific recommendations to improve the design and conduct of clinical trials

There are many reasons why the majority of clinical trials fail or have limited applicability to patient care. These include restrictive entry criteria, short duration studies, unrecognized adverse drug effects, and reporting of therapy assignment preferential to actual use. Frequently, experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupersmith, Mark J., Jette, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084694/
https://www.ncbi.nlm.nih.gov/pubmed/37038147
http://dx.doi.org/10.1186/s13063-023-07276-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084694/
https://www.ncbi.nlm.nih.gov/pubmed/37038147
http://dx.doi.org/10.1186/s13063-023-07276-2

Ejemplares similares